Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Despite a surge in Lee's Pharmaceutical's stock, a modest P/...

Despite a surge in Lee's Pharmaceutical's stock, a modest P/S ratio remains due to expected weak growth. Declining revenue fuels shareholder pessimism and the firm needs a significant turnaround to justify a higher P/S ratio.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
3126 Views
Comment
Sign in to post a comment